Chymase

This MedLibrary.org supplementary page on Chymase is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Chymase with PMSF bound PDB: 1KLT
chymase 1, mast cell
Identifiers
Symbol CMA1
Entrez 1215
HUGO 2097
OMIM 118938
RefSeq NM_001836
UniProt P23946
Other data
EC number 3.4.21.39
Locus Chr. 14 q11.2

Chymases are a family of serine proteases found primarily in mast cells, though also present in basophil granulocytes (e.g. alpha chymase mcpt8). They show broad peptidolytic activity and are involved in a variety of functions. For example, chymases are released by mucosal mast cells upon challenge with parasites and parasite antigens promoting an inflammatory response. Chymases are also known to convert angiotensin I to angiotensin II and thus play a role in hypertension and atherosclerosis.[1]

Because of its role in inflammation it has been investigated as a target in the treatment of asthma[2].

References

  1. ^ Cughey, GH. Mast cell tryptases and chymases in inflammation and host defense. Immu Revs 2007 (217): 141-154.
  2. ^ de Garavilla et al. Journal of Biochemistry 2005(280) pp.18001-18007.

Wikipedia content modification information:

  • This page was last modified on 15 April 2008, at 03:40.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Chymase".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.